Please enable JavaScript to continue using this application.

Compare $IMDX vs $XGN | Chartloom

Compare

$IMDX vs $XGN

Insight Molecular Diagnostics Inc · Exagen Inc

IMDX

Insight Molecular Diagnostics Inc

XGN

Exagen Inc

Compare $IMDX vs $XGN

Comparing Insight Molecular Diagnostics Inc and Exagen Inc

IMDXInsight Molecular Diagnostics Inc

XGNExagen Inc

IMDXInsight Molecular Diagnostics Inc

Market cap

$109M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

58.81x

Rev growth (TTM)

-60.8%

YTD performance

-52.9%

52W performance

-8.4%

FCF yield

-28.4%

XGNExagen Inc

Market cap

$203M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.63x

Rev growth (TTM)

20.8%

YTD performance

39.4%

52W performance

-23.3%

FCF yield

-3.7%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMDX

XGN

Detailed metrics comparison

IMDX

Insight Molecular Diagnostics Inc

XGN

Exagen Inc

Market Cap

IMDX$109M

XGN$203M

Enterprise Value

IMDX$92M

XGN$204M

Price

IMDX$3.37

XGN$8.42

P/E Ratio

IMDXN/A

XGNN/A

P/S Ratio

IMDX65.16x

XGN2.86x

EV/Sales

IMDX54.99x

XGN2.87x

EV/EBITDA

IMDX0.00x

XGN0.00x

P/B Ratio

IMDX102.52x

XGN16.60x

P/FCF Ratio

IMDXN/A

XGNN/A

EV/FCF

IMDX-2.97x

XGN-26.94x

PEG Ratio

IMDXN/A

XGNN/A

Forward P/E (NTM)

IMDXN/A

XGNN/A

Forward P/S (NTM)

IMDX58.81x

XGN2.63x

Revenue (TTM)

IMDX$2M

XGN$71M

Revenue Growth (YoY)

IMDX-60.8%

XGN20.8%

Forward Rev Growth

IMDX593.7%

XGN10.1%

Gross Margin (TTM)

IMDX48.3%

XGN58.6%

Operating Margin (TTM)

IMDX0.0%

XGN0.0%

EBITDA Margin (TTM)

IMDX-1986.2%

XGN-15.1%

Net Margin (TTM)

IMDX-2955.6%

XGN-26.6%

FCF Margin (TTM)

IMDX-1848.8%

XGN-10.7%

Net Income (TTM)

IMDX$-49M

XGN$-19M

FCF (TTM)

IMDX$-31M

XGN$-8M

EPS (TTM)

IMDX-$1.34

XGN-$0.78

ROE (TTM)

IMDX-42668.0%

XGN-12162.0%

ROA (TTM)

IMDX-14147.0%

XGN-3368.0%

ROIC (TTM)

IMDX-37415.0%

XGN-4566.0%

Cash

IMDX$18M

XGN$25M

Debt

IMDX$766K

XGN$26M

Net Cash/Debt

IMDX$17M

XGN$-959K

Current Ratio (TTM)

IMDX2.00x

XGN3.18x

Quick Ratio (TTM)

IMDX1.82x

XGN2.75x

Debt/Equity (TTM)

IMDX0.92x

XGN2.09x

Debt/Assets (TTM)

IMDX0.0%

XGN0.0%

Interest Coverage (TTM)

IMDXN/A

XGNN/A

Net Debt/EBITDA (TTM)

IMDX0.00x

XGN0.00x

Beta

IMDX1.86

XGN2.28

52W Performance

IMDX-8.4%

XGN-23.3%

YTD Performance

IMDX-52.9%

XGN39.4%

% from 52W High

IMDX-60.4%

XGN-31.2%

% from 52W Low

IMDX39.3%

XGN225.1%

Asset Turnover (TTM)

IMDX0.05x

XGN1.27x

FCF Yield (TTM)

IMDX-28.4%

XGN-3.7%

Earnings Yield (TTM)

IMDX-45.4%

XGN-9.3%

Dividend Yield (TTM)

IMDXN/A

XGNN/A

Rule of 40

IMDX-1,909.6

XGN10.2

EV/GP/RG

IMDX10.54

XGN0.55

Ticker research

View IMDX research View XGN research

Metric	IMDX Insight Molecular Diagnostics Inc	XGN Exagen Inc
Market & Valuation
Market Cap	$109M	$203M
Enterprise Value	$92M	$204M
Price	$3.37	$8.42
P/E Ratio	N/A	N/A
P/S Ratio	65.16x	2.86x
EV/Sales	54.99x	2.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	102.52x	16.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.97x	-26.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	58.81x	2.63x
Revenue & Growth
Revenue (TTM)	$2M	$71M
Revenue Growth (YoY)	-60.8%	20.8%
Forward Rev Growth	593.7%	10.1%
Profitability
Gross Margin (TTM)	48.3%	58.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1986.2%	-15.1%
Net Margin (TTM)	-2955.6%	-26.6%
FCF Margin (TTM)	-1848.8%	-10.7%
Net Income (TTM)	$-49M	$-19M
FCF (TTM)	$-31M	$-8M
EPS (TTM)	-$1.34	-$0.78
ROE (TTM)	-42668.0%	-12162.0%
ROA (TTM)	-14147.0%	-3368.0%
ROIC (TTM)	-37415.0%	-4566.0%
Financial Health
Cash	$18M	$25M
Debt	$766K	$26M
Net Cash/Debt	$17M	$-959K
Current Ratio (TTM)	2.00x	3.18x
Quick Ratio (TTM)	1.82x	2.75x
Debt/Equity (TTM)	0.92x	2.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.86	2.28
52W Performance	-8.4%	-23.3%
YTD Performance	-52.9%	39.4%
% from 52W High	-60.4%	-31.2%
% from 52W Low	39.3%	225.1%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	1.27x
FCF Yield (TTM)	-28.4%	-3.7%
Earnings Yield (TTM)	-45.4%	-9.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,909.6	10.2
EV/GP/RG	10.54	0.55
Ticker research	View IMDX research	View XGN research

Valuation

P/S Ratio

XGN

2.86x

IMDX

65.16x

EV/FCF

XGN

-26.94x

IMDX

-2.97x

Growth & revenue

Revenue Growth TTM

XGN

20.8%

IMDX

-60.8%

Forward Revenue Growth

IMDX

593.7%

XGN

10.1%

Profitability & performance

Gross Margin

XGN

58.6%

IMDX

48.3%

ROE

XGN

-12162.0%

IMDX

-42668.0%

FCF Yield %

XGN

-3.7%

IMDX

-28.4%

52-Week Performance

IMDX

-8.4%

XGN

-23.3%

Detailed metrics comparison

IMDX

Insight Molecular Diagnostics Inc

XGN

Exagen Inc

Market Cap

IMDX$109M

XGN$203M

Enterprise Value

IMDX$92M

XGN$204M

Price

IMDX$3.37

XGN$8.42

P/E Ratio

IMDXN/A

XGNN/A

P/S Ratio

IMDX65.16x

XGN2.86x

EV/Sales

IMDX54.99x

XGN2.87x

EV/EBITDA

IMDX0.00x

XGN0.00x

P/B Ratio

IMDX102.52x

XGN16.60x

P/FCF Ratio

IMDXN/A

XGNN/A

EV/FCF

IMDX-2.97x

XGN-26.94x

PEG Ratio

IMDXN/A

XGNN/A

Forward P/E (NTM)

IMDXN/A

XGNN/A

Forward P/S (NTM)

IMDX58.81x

XGN2.63x

Revenue (TTM)

IMDX$2M

XGN$71M

Revenue Growth (YoY)

IMDX-60.8%

XGN20.8%

Forward Rev Growth

IMDX593.7%

XGN10.1%

Gross Margin (TTM)

IMDX48.3%

XGN58.6%

Operating Margin (TTM)

IMDX0.0%

XGN0.0%

EBITDA Margin (TTM)

IMDX-1986.2%

XGN-15.1%

Net Margin (TTM)

IMDX-2955.6%

XGN-26.6%

FCF Margin (TTM)

IMDX-1848.8%

XGN-10.7%

Net Income (TTM)

IMDX$-49M

XGN$-19M

FCF (TTM)

IMDX$-31M

XGN$-8M

EPS (TTM)

IMDX-$1.34

XGN-$0.78

ROE (TTM)

IMDX-42668.0%

XGN-12162.0%

ROA (TTM)

IMDX-14147.0%

XGN-3368.0%

ROIC (TTM)

IMDX-37415.0%

XGN-4566.0%

Cash

IMDX$18M

XGN$25M

Debt

IMDX$766K

XGN$26M

Net Cash/Debt

IMDX$17M

XGN$-959K

Current Ratio (TTM)

IMDX2.00x

XGN3.18x

Quick Ratio (TTM)

IMDX1.82x

XGN2.75x

Debt/Equity (TTM)

IMDX0.92x

XGN2.09x

Debt/Assets (TTM)

IMDX0.0%

XGN0.0%

Interest Coverage (TTM)

IMDXN/A

XGNN/A

Net Debt/EBITDA (TTM)

IMDX0.00x

XGN0.00x

Beta

IMDX1.86

XGN2.28

52W Performance

IMDX-8.4%

XGN-23.3%

YTD Performance

IMDX-52.9%

XGN39.4%

% from 52W High

IMDX-60.4%

XGN-31.2%

% from 52W Low

IMDX39.3%

XGN225.1%

Asset Turnover (TTM)

IMDX0.05x

XGN1.27x

FCF Yield (TTM)

IMDX-28.4%

XGN-3.7%

Earnings Yield (TTM)

IMDX-45.4%

XGN-9.3%

Dividend Yield (TTM)

IMDXN/A

XGNN/A

Rule of 40

IMDX-1,909.6

XGN10.2

EV/GP/RG

IMDX10.54

XGN0.55

Ticker research

View IMDX research View XGN research

Metric	IMDX Insight Molecular Diagnostics Inc	XGN Exagen Inc
Market & Valuation
Market Cap	$109M	$203M
Enterprise Value	$92M	$204M
Price	$3.37	$8.42
P/E Ratio	N/A	N/A
P/S Ratio	65.16x	2.86x
EV/Sales	54.99x	2.87x
EV/EBITDA	0.00x	0.00x
P/B Ratio	102.52x	16.60x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.97x	-26.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	58.81x	2.63x
Revenue & Growth
Revenue (TTM)	$2M	$71M
Revenue Growth (YoY)	-60.8%	20.8%
Forward Rev Growth	593.7%	10.1%
Profitability
Gross Margin (TTM)	48.3%	58.6%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1986.2%	-15.1%
Net Margin (TTM)	-2955.6%	-26.6%
FCF Margin (TTM)	-1848.8%	-10.7%
Net Income (TTM)	$-49M	$-19M
FCF (TTM)	$-31M	$-8M
EPS (TTM)	-$1.34	-$0.78
ROE (TTM)	-42668.0%	-12162.0%
ROA (TTM)	-14147.0%	-3368.0%
ROIC (TTM)	-37415.0%	-4566.0%
Financial Health
Cash	$18M	$25M
Debt	$766K	$26M
Net Cash/Debt	$17M	$-959K
Current Ratio (TTM)	2.00x	3.18x
Quick Ratio (TTM)	1.82x	2.75x
Debt/Equity (TTM)	0.92x	2.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.86	2.28
52W Performance	-8.4%	-23.3%
YTD Performance	-52.9%	39.4%
% from 52W High	-60.4%	-31.2%
% from 52W Low	39.3%	225.1%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	1.27x
FCF Yield (TTM)	-28.4%	-3.7%
Earnings Yield (TTM)	-45.4%	-9.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,909.6	10.2
EV/GP/RG	10.54	0.55
Ticker research	View IMDX research	View XGN research